BOSTON--(BUSINESS WIRE)--LaVoieHealthScience (LHS), an integrated investor and public relations agency focused on advancing health and science innovations, today announced that former specialty pharmaceutical analyst, Chiara Russo joined the LHS team as Director, Investor Relations. In addition, LHS announced new clients, the life science accelerator, Xontogeny LLC and electroceutical pioneer, Iota BioSciences.

Ms. Russo joins LHS from Cantor Fitzgerald, LLC, where she was Director, Research Analyst covering various small to mid-cap specialty pharma/biotech companies across a multitude of therapeutic areas leading to a significant industry network. She has been quoted in many news outlets such as Bloomberg, Reuters, TheStreet and Bezinga and accompanied company executives on numerous non-deal roadshows in major investor centers. Prior to her role at Cantor, Chiara was Vice President, Research Analyst at Janney Montgomery Scott, LLC, having started her career at Think Equity LLC.

“Continuing to add experienced health and science communications talent to our team is an important part of our strategy for growth,” said Donna L. LaVoie, President & CEO of LaVoieHealthScience. “With our continued focus in providing an integrated solution in both investor and public relations to our clients, adding Chiara to the team provides us with additional bench strength in IR and financial communications.”

“I am excited to already be applying my skills as an analyst to help LHS’ clients with story-telling and their investment thesis along with an insider’ view on how news is viewed and potential institutional targets,” said Russo.

Xontogeny LLC, founded by former Sarepta CEO and serial entrepreneur, Chris Garabedian, is a biotech aggregator that supports the accelerated development of life science technologies in the pursuit of helping patients with serious diseases. Xontogeny partners with entrepreneurs, providing the leadership and operating experience needed to increase the probability of success with early drug and technology development.

Iota BioSciences, founded in Berkeley, CA, is an emerging electroceutical company revolutionizing the use of “vanishingly small” wireless, battery less sensors, bringing closer a time when a Fitbit-like device could monitor internal nerves, muscles, or organs in real time.

“As this is our fourth time making the Inc. 5000 fastest-growing private company list, we are proud of the team’s accomplishments and to add these clients to our list of movers and shakers in the health and sciences field,” said Donna LaVoie, President & CEO of LaVoieHealthScience. “The LHS team is excited to help these emerging health and science innovators add value and grow.”

About LaVoieHealthScience

LaVoieHealthScience partners with leading life science brands to build value for their companies, attract capital and reach key stakeholders through integrated communications and marketing. The firm provides strategic communications, investor relations and public relations to build recognition and increase sales and value for health science innovations. The agency has received 29 awards over the past seven years in recognition of the work it has done for its health and science industry-leading clients, and is ranked among the 2017 Inc. 5000 list of fastest growing private companies for the fourth year. In addition to clients listed above, LaVoieHealthScience represents leaders such as Biotechnology Innovation Organization, Cydan Development, Imara, NewLink Genetics, Newron Pharmaceuticals, Origenis, and other emerging health and science companies.